A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital tumor suppressor protein is frequently disabled in many forms of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research